Search Results

Showing 10 from 85 results

New trends in clinical studies for patients

  1. USA
  2. News & Media
  3. Feature Stories
Shoshi Friedman highlights the latest trends in the sector from greater accessibility to increased diversity and why they are essential for growth

What are the 3 biggest elements shaping clinical development today

  1. USA
  2. News & Media
  3. Feature Stories
From the increased incorporation of patient perspectives to the growing rise of technology in research Teva s Head of Global Early Clinical Development Eran Harary outlines the trends he s watching

Why Diversity in Clinical Trials is So Important

  1. USA
  2. News & Media
  3. Feature Stories
Clinical trials are essential for the development of medicines and it s increasingly recognised there is a growing need for diversity in these trials Teva investigates why and outlines how it is working to increase diverse representation in clinical trials

Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress

Teva s Reslizumab Delivers Clinically and Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase III Studies

Facts Figures

  1. USA
  2. About Teva

Meet the Expert Paula Turner

  1. USA
  2. News & Media
  3. Feature Stories

CONNECT1 Study Published in Journal of Allergy and Clinical Immunology In Practice Evaluates the Potential of ProAir Digihaler albuterol sulfate Inhalation Powder and Digihaler System to Help Improve Asthma Management

Studies Show Effectiveness of AJOVY fremanezumab for Treatment of Migraine in Patients With Co morbid Depression

Can AI driven digital biomarkers redefine diagnostics and clinical trials

  1. USA
  2. News & Media
  3. Feature Stories
Artificial Intelligence and advanced analytics technologies have huge potential to improve the world of health We talk to Teva employees who are using the technologies